期刊文献+

环孢素与氟康唑合用致重度免疫抑制1例 被引量:2

下载PDF
导出
摘要 钙调蛋白磷酸酶抑制剂(CNI)是预防和治疗移植物抗宿主病(GVHD)最为常用的药物。环孢素是一种全身免疫抑制剂,是造血干细胞移植的一线用药。环孢素主要经CYP3A4代谢,个体差异十分大,且许多药物可影响其代谢。氟康唑是一种常用的唑类抗真菌药,体外研究显示其能升高环孢索血药浓度。目前国内尚未见环孢素与氟康唑合用致重度免疫抑制的报道,我院一患者应用环孢素与氟康唑后重度免疫抑制,最终发展为重症性肺炎,现报道如下。
出处 《海峡药学》 2016年第11期271-272,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献3

二级参考文献56

  • 1Harter C. Sehulze B, Gohtschmidt H, et al. Piperacillin/ tazobactam vs ceflazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial [ J ]. Bone Marrow Transplantation, 2006,37 (2) : 373 - 9.
  • 2Kruger W, Rtissmann B , Kruger N, et al . Early infections in pa- tients undergoing bone marrow or blood stem cell transplantation a 7-year single centre investigation of 409 cases[J]. Bone Mar- row Transplantation , 1999 ,23 ( 6 ) : 589 - 97.
  • 3Michallet M,Ito JI.Approaches to the management of invasive fungal infections in hematologic malignancyand hematopoietic cell transplantation[J].J Clin Oncol,2009,27(20):3398-3409.
  • 4Li L,Wang J,Zhang W,et al.Risk factors for invasive mold infections following allogeneic hematopoietic stem celltransplantation:a single center study of 190recipients[J].Scand J Infect Dis,2012,44(2):100-107.
  • 5SinkóJ,Bryan J.Managing invasive fungal infection in hematopoietic stem-cell transplantation[J].Future Microbiol,2010,5(9):1309-1314.
  • 6Kontoyiannis DP,Marr KA,Park BJ,et al.Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients,2001-2006:overview of the Transplant-Associated Infection Surveillance Network(TRANSNET)Database[J].Clin Infect Dis,2010,50(8):1091-1100.
  • 7Neofytos D,Horn D,Anaissie E,et al.Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem celltransplant recipients:analysis of multicenter prospective antifungal therapy(PATH)alliance registry[J].Clin Infect Dis,2009,48(3):265-273.
  • 8Almyroudis NG,Segal BH.Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients[J].Expert Rev Anti Infect,2010,8(12):1451-1466.
  • 9Ostrosky-Zeichner L,Marr KA,Rex JH,et al.Amphotericin B:time for a new"gold standard"[J].Clin Infect Dis,2003,37(3):415-425.
  • 10Wade RL,Chaudhari P,Natoli JL,et al.Comparison of adverse events and hospital length of stay associated with variousamphotericin B formulations:sequential conventional amphotericin b/lipid versus lipid-onlytherapy for the treatment of invasive fungal infections in hospitalized patients[J].P T,2013,38(5):278-287.

共引文献12

同被引文献16

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部